Comparison of Efficacy of Microneedling With Platelet Rich Plasma Vs Microneedling With Topical Insulin in the Treatment of Acne Scars
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Microneedling with autologous Platelet Rich Plasma, Microneedling with topical insulin.
- Who it may be relevant to
- Registry conditions: Post-acne Atrophic Scars. Basic parameters: 18 years — 50 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Pakistan
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Comparison of Efficacy of Microneedling With Autologous Platelet-Rich Plasma vs Microneedling With Topical Insulin in the Treatment of Atrophic Acne Scars
Overview
This study compares the outcome of two procedures for the treatment of atrophic acne scars.
Detailed description
Post acne scars develop due to severely inflamed and nodulocystic acne. Numerous methods exist for the treatment of post acne scars including lasers , microneedling and chemical peels etc . This study is to compare the efficacy two procedures.
Interventions
- Procedure Microneedling with autologous Platelet Rich Plasma
Patients in group A will undergo Microneedling with autologous PRP - Procedure Microneedling with topical insulin
Patients in group B will undergo Microneedling with Topical insulin ( regular).
Primary outcome measures
- Efficacy of treatment [Time frame: 6 months]
Eligibility criteria
Inclusion criteria
Patients confirmed with post-acne atrophic scars . No prior treatment for scars in last 6 months.
\-
Exclusion criteria
- Patient with active acne or other skin conditions (e.g eczema , psoriasis). Patients on oral or topical retinoids. Pregnant or lactating Mothers. Patients with recurrent herpes simplex infection. Previous Hx of keloids / hypertrophic scarring. Deranged blood glucose levels. Bleeding disorders
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Pakistan · 1 center
- Khyber Teaching Hospital — Peshawar
Identifiers
NCT: NCT06978361 · 938/DME/KMC